Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-4856

Sonda, S; Stefanic, S; Hehl, A B (2008). A sphingolipid inhibitor induces a cytokinesis arrest and blocks stage differentiation in Giardia lamblia. Antimicrobial Agents and Chemotherapy, 52(2):563-569.

View at publisher


Sphingolipid biosynthesis pathways have recently emerged as a promising target for therapeutic intervention
against pathogens, including parasites. A key step in the synthesis of complex sphingolipids is the glucosylation
of ceramide, mediated by glucosylceramide (GlcCer) synthase, whose activity can be inhibited by PPMP
(1-phenyl-2-palmitoylamino-3-morpholino-1-propanol). In this study, we investigated whether PPMP inhibits
the proliferation and differentiation of the pathogenic parasite Giardia lamblia, the major cause of parasiteinduced
diarrhea worldwide. PPMP was found to block in vitro parasite replication in a dose-dependent
manner, with a 50% inhibitory concentration of 3.5 M. The inhibition of parasite replication was irreversible
at 10 MPPMP, a concentration that did not affect mammalian cell metabolism. Importantly, PPMP inhibited
the completion of cell division at a specific stage in late cytokinesis. Microscopic analysis of cells incubated with
PPMP revealed the aberrant accumulation of cellular membranes belonging to the endoplasmic reticulum
network in the caudal area of the parasites. Finally, PPMP induced a 90% reduction in G. lamblia differentiation
into cysts, the parasite stage responsible for the transmission of the disease. These results show that
PPMP is a powerful inhibitor of G. lamblia in vitro and that as-yet-uncharacterized sphingolipid biosynthetic
pathways are potential targets for the development of anti-G. lamblia agents.


10 citations in Web of Science®
11 citations in Scopus®
Google Scholar™



114 downloads since deposited on 18 Nov 2008
23 downloads since 12 months

Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:05 Vetsuisse Faculty > Institute of Parasitology
04 Faculty of Medicine > Institute of Parasitology
Dewey Decimal Classification:570 Life sciences; biology
610 Medicine & health
600 Technology
Date:February 2008
Deposited On:18 Nov 2008 15:42
Last Modified:05 Apr 2016 12:32
Publisher:American Society for Microbiology
Additional Information:Copyright: American Society for Microbiology
Publisher DOI:10.1128/AAC.01105-07
PubMed ID:18086854

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page